Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Doxorubicin in breast cancer

Aas, T., Bprresen, A.-L., Geisler, S., Smith-Sorensen, B., Johansen, H., Varhaug, J., Akslen, L., and Lonning, P. (1996) Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med. 2,811-814. [Pg.196]

See other pages where Doxorubicin in breast cancer is mentioned: [Pg.266] [Pg.245]

See also in sourсe #XX -- [ Pg.131 , Pg.1310 , Pg.1312 , Pg.1319 ]

See also in sourсe #XX -- [ Pg.682 , Pg.683 , Pg.684 ]

See also in sourсe #XX -- [ Pg.682 , Pg.683 , Pg.684 ]

See also in sourсe #XX -- [ Pg.2346 , Pg.2347 , Pg.2347 , Pg.2348 , Pg.2356 ]

SEARCH

Cancer doxorubicin

Doxorubicin

Doxorubicin breast cancer

Doxorubicine